Skip to menu Skip to content Skip to footer

2010

Journal Article

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

Nowak, Anna K., Francis, Roslyn J., Phillips, Michael J., Millward, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan, Musk, Arthur W., McCoy, Melanie J., Segal, Amanda, Robins, Peter, Byrne, Michael J. and Jolghazi, Anna (2010). A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clinical Cancer Research, 16 (8), 2409-2417. doi: 10.1158/1078-0432.CCR-09-2313

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

2009

Journal Article

A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma

Dancey, Gairin, Violet, John, Malaroda, Alessandra, Green, Alan J., Sharma, Surinder K., Francis, Roslyn, Othman, Shokri, Parker, Sweta, Buscombe, John, Griffin, Natalie, Chan, Pei-San, Malhotra, Anmol, Woodward, Nicholas, Ramsay, Alan, Ross, Philip, Lister, T. Andrew, Amlot, Peter, Begent, Richard and McNamara, Christopher (2009). A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma. Clinical Cancer Research, 15 (24), 7701-7710. doi: 10.1158/1078-0432.CCR-09-1421

A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma

2008

Journal Article

Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study

Boucek, J. A., Francis, R. J., Jones, C. G., Khan, N., Turlach, B. A. and Green, A. J. (2008). Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study. Physics in Medicine and Biology, 53 (16), 4213-4230. doi: 10.1088/0031-9155/53/16/001

Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study

2008

Journal Article

Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results

Green, A. J., Francis, R. J., Baig, S. and Begent, R. H.J. (2008). Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results. European Journal of Nuclear Medicine and Molecular Imaging, 35 (2), 393-406. doi: 10.1007/s00259-007-0602-3

Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results

2007

Journal Article

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans

Francis, Roslyn J., Byrne, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan A., Nowak, Anna K., Phillips, Michael, Price, Richard, Patrikeos, Andrew P., Musk, A. William and Millward, Michael J. (2007). Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. Journal of Nuclear Medicine, 48 (9), 1449-1458. doi: 10.2967/jnumed.107.042333

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans

2006

Journal Article

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug

Mayer, Astrid, Francis, Roslyn J., Sharma, Surinder K., Tolner, Berend, Springer, Caroline J., Martin, Jan, Boxer, Geoff M., Bell, James, Green, Alan J., Hartley, John A., Cruickshank, Clare, Wren, Julie, Chester, Kerry A. and Begent, Richard H. J. (2006). A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clinical Cancer Research, 12 (21), 6509-6516. doi: 10.1158/1078-0432.CCR-06-0769

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug